DaShenLin Pharmaceutical Group Co., Ltd.

¥21.49As of Sun 8 Nov 2026, 12:00 UTC
SSE:603233Healthcare
Country China
PE (Fwd) •••
TSR 9Y CAGR 7.75%
Div yield 4.19%
ROE 18.00%
Pharmaceutical Retailers
Beta (5Y) 0.33
PE TTM 17.21
TSR TTM 26.35%
Mkt cap ¥24.47B
ROIC 21.37%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥22
0.89%
(77.72%)
Hold 12|3|7|7|9
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.27
0.27
0.27
0.28
13.30%
8.53%
0.25%
0.79%
Revenue¥B
1.543
1.579
1.663
1.720
9.30%
12.66%
17.34%
15.47%
Peers (US$3.669B)
Cap (US$)
PE
1.703B
24.45x
Capital
TTM
5Y
10Y
Leveragex
0.568
0.343
0.290
EBIT/Intx
1.253
0.139
0.171
Own earn%
(14.91)
37.57
36.36
Sh yield%
32.76
19.24
20.05
Owners
Insiders/Inst%
14.76
56.01
Short interest%
5.37
SBC / revenue%
1.06
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
3–14
$1 testx
0.0
Incr. ROIC%
13